Table 3.

Logistic regression models for the presence / absence of neuropathy and falls within cancer subjects using PC scores. Bold values indicate significant effects (p < 0.05).

	Estimate	SE	P-value
Neuropathy (presence/absence); (n = 434)
(Intercept)	−2.003	1.088	0.066
PC1 Magnitude	0.020	0.024	0.399
PC2 R / AP Jerk & Frequency	0.092	0.035	0.009
PC3 ML Frequency	−0.015	0.043	0.720
Age	0.020	0.016	0.200
BMI	0.034	0.016	0.029
Time Since Chemo	−0.005	0.002	0.014
Falls (>=1 in past 6 months); (n = 434)
(Intercept)	−2.836	1.326	0.032
PC1 Magnitude	0.049	0.029	0.089
PC2 R / AP Jerk & Frequency	−0.051	0.043	0.242
PC3 ML Frequency	−0.116	0.052	0.026
Age	0.014	0.020	0.485
BMI	0.011	0.018	0.536
CIPN+	0.793	0.255	0.002
Time Since Chemo	−0.004	0.003	0.158
Falls (>=1 in past 6 months) in CIPN+ subjects; (n = 216)
(Intercept)	−2.549	1.858	0.170
PC1 Magnitude	0.169	0.083	0.041
PC2 R / AP Jerk & Frequency	−0.346	0.143	0.016
PC3 ML Frequency	0.210	0.180	0.245
Age	−0.006	0.028	0.830
BMI	0.022	0.024	0.363
Neuropathy Severity	0.278	0.165	0.092
Time Since Chemo	−0.005	0.004	0.194
PC1 * Neuropathy Severity	−0.050	0.032	0.112
PC2 * Neuropathy Severity	0.129	0.052	0.013
PC3 * Neuropathy Severity	−0.156	0.073	0.033